We are on the cusp of a biobased industrial revolution. Thanks to advances in biotechnology, the cost and performance of bio-manufactured products such as plastics and chemicals and their building blocks will soon far surpass oil-derived incumbents, opening up possibilities that are hard to even fathom today, with a market size of 2 trillion USD by 2030.

The current biomanufacturing processes are costly and inefficient. And as a result of this, most biomanufacturers still struggle to compete at scale.

Advances in enzyme technology have been transformative for biorefinery. These biocatalysts achieve the specificity and activity needed for efficient conversion of biomass into high-value building blocks, opening up whole new possibilities for biomanufacturers. However, enzymes suffer from fundamental limitations which hold back their further adoption: they are prohibitively expensive, single-use, and unstable in harsh conditions.

Level Nine are developing the world’s first nanozymes for use in industrial biomanufacturing. Their nanozymes mimic the activity and specificity of natural enzymes, while overcoming their limitations: they are vastly cheaper to produce, can achieve enhanced stability and activity, and are reusable over many production cycles. In short, the next generation catalysts that biomanufacturers need to successfully compete with fossil-derived products at scale.